Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 481405, 8 pages
http://dx.doi.org/10.1155/2015/481405
Research Article

Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3

1Shandong Provincial Qianfoshan Hospital, Jinan 250014, China
2Weifang Medical University, Weifang 261031, China
3Binzhou Medical University, Yantai 264003, China
4Pharmacy School, Shihezi University, Shihezi 832002, China

Received 23 September 2014; Revised 9 November 2014; Accepted 11 November 2014

Academic Editor: Yanfang Chen

Copyright © 2015 Mingjie Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Fan, L. Chen, S. Cheng et al., “Aging aggravates nitrate-mediated ROS/RNS changes,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 376515, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Juhaszova, D. B. Zorov, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott, “Role of glycogen synthase kinase-3β in cardioprotection,” Circulation Research, vol. 104, no. 11, pp. 1240–1252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Jennings, “Historical perspective on the pathology of myocardial ischemia/reperfusion injury,” Circulation Research, vol. 113, no. 4, pp. 428–438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Przyklenk, Y. Dong, V. V. Undyala, and P. Whittaker, “Autophagy as a therapeutic target for ischaemia/reperfusion injury? Concepts, controversies, and challenges,” Cardiovascular Research, vol. 94, no. 2, pp. 197–205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Liu, J. Wang, W. Zhou, Y. Wang, and L. Yang, “Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice,” Journal of Ethnopharmacology, vol. 146, no. 3, pp. 773–793, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ali, K. P. Hoeflich, and J. R. Woodgett, “Glycogen synthase kinase-3: properties, functions, and regulation,” Chemical Reviews, vol. 101, no. 8, pp. 2527–2540, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. H. Ramirez, S. Fan, M. Zhang et al., “Inhibition of glycogen synthase kinase 3β (GSK3β) decreases inflammatory responses in brain endothelial cells,” The American Journal of Pathology, vol. 176, no. 2, pp. 881–892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Cuzzocrea, C. Crisafulli, E. Mazzon et al., “Inhibition of glycogen synthase kinase-3β attenuates the development of carrageenan-induced lung injury in mice,” British Journal of Pharmacology, vol. 149, no. 6, pp. 687–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. H. Sugden, S. J. Fuller, S. C. Weiss, and A. Clerk, “Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis,” British Journal of Pharmacology, vol. 153, no. S1, pp. S137–S153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mora, K. Sakamoto, E. J. McManus, and D. R. Alessi, “Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart,” FEBS Letters, vol. 579, no. 17, pp. 3632–3638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Juhaszova, D. B. Zorov, S.-H. Kim et al., “Glycogen synthase kinase-3β mediates convergence of protection signalling to inhibit the mitochondrial permeability transition pore,” Journal of Clinical Investigation, vol. 113, no. 11, pp. 1535–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Nishihara, T. Miura, T. Miki et al., “Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection,” Journal of Molecular and Cellular Cardiology, vol. 43, no. 5, pp. 564–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang, “Flavonoids: promising anticancer agents,” Medicinal Research Reviews, vol. 23, no. 4, pp. 519–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. López-Lázaro, “Distribution and biological activities of the flavonoid luteolin,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 1, pp. 31–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Verma, M. Vijayakumar, C. S. Mathela, and C. V. Rao, “In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves,” Food and Chemical Toxicology, vol. 47, no. 9, pp. 2196–2201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Park, E. K. Lee, H.-S. Heo et al., “The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinase pathways,” Journal of Medicinal Food, vol. 12, no. 2, pp. 351–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Gates, S. S. Tworoger, J. L. Hecht, I. de Vivo, B. Rosner, and S. E. Hankinson, “A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer,” International Journal of Cancer, vol. 121, no. 10, pp. 2225–2232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Zweier, J. Fertmann, and G. Wei, “Nitric oxide and peroxynitrite in postischemic myocardium,” Antioxidants & Redox Signaling, vol. 3, no. 1, pp. 11–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Wang, P. Xu, H. Liu, Y. Zhou, and X. Cao, “The protection of salidroside of the heart against acute exhaustive injury and molecular mechanism in rat,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 507832, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Pang, B. Han, T. Yu, and Z. Peng, “The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy,” PLoS ONE, vol. 9, no. 3, Article ID e92216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Xia, Y. Chen, Q. Fan, and M. Xue, “Oxidative stress-mediated reperfusion injury: mechanism and therapies,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 373081, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Google Scholar · View at Scopus
  24. Y. Wang, X. Li, X. Wang et al., “Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway,” PLoS ONE, vol. 8, no. 8, Article ID e70956, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. B. S. Cain, D. R. Meldrum, C. A. Dinarello et al., “Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function,” Critical Care Medicine, vol. 27, no. 7, pp. 1309–1318, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sugano, T. Hata, K. Tsuchida et al., “Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 127–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Korge, P. Ping, and J. N. Weiss, “Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide,” Circulation Research, vol. 103, no. 8, pp. 873–880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Miura and T. Miki, “GSK-3β, a therapeutic target for cardiomyocyte protection,” Circulation Journal, vol. 73, no. 7, pp. 1184–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Wyllie, “Clues in the p53 murder mystery,” Nature, vol. 389, no. 6648, pp. 237–238, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Korge, H. M. Honda, and J. N. Weiss, “Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 3312–3317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Borutaite, A. Jekabsone, R. Morkuniene, and G. C. Brown, “Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 4, pp. 357–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-S. Park, H. Zhao, Y. Jang, R. A. Mueller, and Z. Xu, “N6-(3-Iodobenzyl)-adenosine-5′-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3β,” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 1, pp. 124–131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Feng, E. Lucchinetti, P. Ahuja, T. Pasch, J.-C. Perriard, and M. Zaugg, “Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3β,” Anesthesiology, vol. 103, no. 5, pp. 987–995, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. H. K. Gao, Z. Yin, N. Zhou, X. Y. Feng, F. Gao, and H. C. Wang, “Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis,” Journal of Cardiovascular Pharmacology, vol. 52, no. 3, pp. 286–292, 2008. View at Publisher · View at Google Scholar · View at Scopus